Cytokinetics
CYTK
C$49.81
Share price
-1.15%
Change (1 day)
-32.47%
Change (1 year)
Categories
EPS for Cytokinetics (CYTK)
EPS in 2025 (TTM): C-$7.40
According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is C-$7.29. In 2024 the company made an earnings per share (EPS) of C-$7.25 an increase over its 2023 EPS that were of C-$7.51.
EPS history for Cytokinetics from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | C-$7.40 | 2.08% |
| 2024 | C-$7.25 | -3.49% |
| 2023 | C-$7.51 | 28.24% |
| 2022 | C-$5.85 | 50.18% |
| 2021 | C-$3.90 | 40.8% |
| 2020 | C-$2.77 | |
| 2018 | C-$2.69 | -24.12% |
| 2017 | C-$3.54 | -776.32% |
| 2016 | C$0.52 | -139.18% |
| 2015 | C-$1.34 | 125.58% |
| 2014 | C-$0.59 | -67.67% |
| 2013 | C-$1.83 | -44.58% |
| 2012 | C-$3.31 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | C-$9.81 | 34.59% | 🇺🇸 USA |
 Trevena TRVN | C-$47.85 | 556.71% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | C-$69.30 | 851.04% | 🇺🇸 USA |
 Amgen AMGN | C$15.22 | -308.88% | 🇺🇸 USA |
 Array Technologies ARRY | C-$2.55 | -65.03% | 🇺🇸 USA |